Multiple sclerosis may not put you at risk for breast, colorectal cancers
People with multiple sclerosis (MS) may not be at higher risk of developing two of…
Browsing: Bladder Cancer
Gemcitabine and daily radiotherapy for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for…
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
In the scientific journal Nature Medicine, researchers at the Netherlands show that neoadjuvant immunotherapy using a…
Dual checkpoint blockade promising as pre-surgical approach for certain patients with localised bladder cancer
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
Urine-based liquid biopsy test outperforms urine cytology in detecting bladder cancer
Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better…
Immunotherapy improves survival in advanced bladder cancer patients
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…
International team identifies a new regulatory pathway in bladder cancer
Researchers from Johns Hopkins University, USA, in collaboration with Insilico Medicine announce the publication of…
Antibiotic overuse reduces bladder cancer survival rates
The over prescribing of antibiotics is reducing survival rates in patients with urothelial carcinoma and…
Combination biomarker predicts response to immune checkpoint therapy in patients with advanced bladder cancer
In patients with metastatic bladder cancer, a novel combination of biomarkers from baseline tumour tissues…
Dire shortage of BCG impacts treatment of bladder cancer patients
Leading Australian urologist Professor Dickon Hayne has been one of the many health professionals happy…